2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Marathon Pharmaceuticals, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001 0.6 mL, MP-101 (10 mg/mL, Opium Tincture (OT)), USP (Deodorized) - Short Bowel Syndrome, Short Gut Syndrome | Phase 3 | Withdrawn | Marathon Pharmaceuticals, LLC | 2015-02-01 | 2015-02-18 | |
| A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals Opium Tincture USP Deodorized - Short Bowel Syndrome, Short Gut Syndrome | Phase 3 | Withdrawn | Marathon Pharmaceuticals, LLC | 2014-12-01 | 2015-02-18 |
United States (2)